WALTHAM, Mass., April 27 /PRNewswire-FirstCall/ -- Inverness
Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling
individuals to take charge of their health at home through the
merger of rapid diagnostics and health management, announced today
that it will attend the Deutsche Bank 35th Annual Health Care
Conference being held May 3 through 5,
2010 at the Intercontinental Hotel in Boston, Massachusetts. Ron Zwanziger, Chief
Executive Officer, and Jon Russell,
Vice President, Finance, will attend. Mr. Zwanziger's presentation
is scheduled for Wednesday, May 5,
2010 at 1:35 p.m., and will be
made available to the public through a webcast accessible via
http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=IMA&item_id=3010138
as well as through the company's website at
http://www.invmed.com/investors.cfm. A replay of the webcast
will be available via the links above for approximately 30 days
from the date of the webcast. During his presentation, Mr.
Zwanziger may discuss and answer questions concerning business and
financial developments and trends. His responses to
questions, as well as other matters discussed during the webcast,
may contain or constitute information that has not been disclosed
previously.
By developing new capabilities in near-patient diagnosis,
monitoring and health management, Inverness Medical Innovations
enables individuals to take charge of improving their health and
quality of life. A global leader in rapid point-of-care
diagnostics, Inverness' products, as well as its new product
development efforts, focus on infectious disease, cardiology,
oncology, drugs of abuse and women's health. Inverness is
headquartered in Waltham,
Massachusetts.
SOURCE Inverness Medical Innovations, Inc.